PL2697369T3 - Nowe sposoby oczyszczania białek - Google Patents

Nowe sposoby oczyszczania białek

Info

Publication number
PL2697369T3
PL2697369T3 PL12763521T PL12763521T PL2697369T3 PL 2697369 T3 PL2697369 T3 PL 2697369T3 PL 12763521 T PL12763521 T PL 12763521T PL 12763521 T PL12763521 T PL 12763521T PL 2697369 T3 PL2697369 T3 PL 2697369T3
Authority
PL
Poland
Prior art keywords
protein purification
purification methods
novel protein
novel
methods
Prior art date
Application number
PL12763521T
Other languages
English (en)
Inventor
Arick Brown
Junyan Ji
Jun Liu
Yuchang John Wang
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46931857&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2697369(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL2697369T3 publication Critical patent/PL2697369T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14351—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL12763521T 2011-03-25 2012-03-23 Nowe sposoby oczyszczania białek PL2697369T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161467897P 2011-03-25 2011-03-25
PCT/US2012/030265 WO2012134987A1 (en) 2011-03-25 2012-03-23 Novel protein purification methods
EP12763521.7A EP2697369B1 (en) 2011-03-25 2012-03-23 Novel protein purification methods

Publications (1)

Publication Number Publication Date
PL2697369T3 true PL2697369T3 (pl) 2018-12-31

Family

ID=46931857

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12763521T PL2697369T3 (pl) 2011-03-25 2012-03-23 Nowe sposoby oczyszczania białek

Country Status (17)

Country Link
US (1) US10906934B2 (pl)
EP (1) EP2697369B1 (pl)
KR (1) KR20140022845A (pl)
CN (1) CN103582700B (pl)
AU (1) AU2012237026A1 (pl)
BR (1) BR112013024521A2 (pl)
CA (1) CA2830640A1 (pl)
ES (1) ES2685079T3 (pl)
HR (1) HRP20181357T1 (pl)
IL (1) IL228438A0 (pl)
MX (1) MX2013010737A (pl)
PL (1) PL2697369T3 (pl)
RU (1) RU2013147609A (pl)
SG (1) SG193564A1 (pl)
SI (1) SI2697369T1 (pl)
TR (1) TR201810703T4 (pl)
WO (1) WO2012134987A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
TW201516149A (zh) 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
CA2932207A1 (en) 2008-10-20 2010-12-09 Abbvie Inc. Isolation and purification of antibodies using protein a affinity chromatography
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
PL2697369T3 (pl) 2011-03-25 2018-12-31 F.Hoffmann-La Roche Ag Nowe sposoby oczyszczania białek
US8933009B2 (en) 2013-03-12 2015-01-13 Ecolab Usa Inc. Surfactant blends for cleaning filtration membranes
CN115177759B (zh) 2013-11-15 2024-07-23 豪夫迈·罗氏有限公司 使用环保洗涤剂的病毒灭活方法
EP3187582B1 (en) * 2014-08-27 2025-07-23 Godo Shusei Co., Ltd. Lactase solution
US11697800B2 (en) 2015-11-05 2023-07-11 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Method for the separation of virus compositions including depletion and purification thereof
EP3639911B1 (en) 2017-06-12 2024-07-31 Asahi Kasei Medical Co., Ltd. Filtration method for protein-containing liquid
JP7074845B2 (ja) 2017-09-29 2022-05-24 エコラボ ユーエスエー インコーポレイティド プロセス膜洗浄における延長界面活性剤の使用
WO2019086463A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
JP7334174B2 (ja) 2018-02-14 2023-08-28 エコラボ ユーエスエー インコーポレイティド 膜からバイオフィルムおよび胞子を低減するための組成物および方法
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
AU2020268896B2 (en) 2019-05-03 2024-11-28 F. Hoffmann-La Roche Ag Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
EP4073084A1 (en) * 2019-12-12 2022-10-19 Nutrition & Biosciences USA 1, LLC Protein bioprocess
AU2021208515A1 (en) 2020-01-15 2022-08-04 F. Hoffmann-La Roche Ag Methods to decrease impurities from recombinant protein manufacturing processes
JP2023532473A (ja) * 2020-07-10 2023-07-28 グリフォルス・ワールドワイド・オペレーションズ・リミテッド ヒト血漿由来免疫グロブリンmを含む組成物を得るための方法
CN116348475A (zh) * 2020-07-15 2023-06-27 营养与生物科学美国1有限责任公司 表面上结垢减少的生物工艺
IL302333A (en) 2020-10-30 2023-06-01 Genentech Inc Purification platforms for obtaining pharmaceutical preparations with a reduced hydrolytic enzyme activity rate
CN115779683B (zh) * 2022-12-16 2024-03-22 康日百奥生物科技(苏州)有限公司 除病毒过滤方法
US20250084125A1 (en) 2023-09-08 2025-03-13 Genentech, Inc. High viscosity ultrafiltration/diafiltration and single-pass tangential flow filtration processes

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4618533A (en) 1984-11-30 1986-10-21 Millipore Corporation Porous membrane having hydrophilic surface and process
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5017292A (en) * 1990-05-10 1991-05-21 Millipore Corporation Membrane, process and system for isolating virus from solution
DE69233528T2 (de) 1991-11-25 2006-03-16 Enzon, Inc. Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
EP0772488B1 (en) 1994-07-28 2001-01-31 Millipore Corporation Porous composite membrane and process
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5888401A (en) 1996-09-16 1999-03-30 Union Camp Corporation Method and apparatus for reducing membrane fouling
US20070059302A1 (en) * 1997-04-07 2007-03-15 Genentech, Inc. Anti-vegf antibodies
US6096872A (en) 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
WO2002013859A1 (en) * 2000-08-10 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Method of inhibiting antibody-containing solution from coagulating or becoming turbid
US20030138417A1 (en) 2001-11-08 2003-07-24 Kaisheva Elizabet A. Stable liquid pharmaceutical formulation of IgG antibodies
US7118675B2 (en) 2002-02-04 2006-10-10 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
CA2478047C (en) * 2002-03-01 2014-01-21 Immunomedics, Inc. Rs7 antibodies
CA2489123C (en) * 2002-06-14 2011-03-15 Centocor, Inc. Use of a clathrate modifier to promote passage of proteins during nanofiltration
AU2003251592A1 (en) * 2002-06-21 2004-01-06 Biogen Idec Inc. Buffered formulations for concentrating antibodies and methods of use thereof
US20040106184A1 (en) * 2002-08-28 2004-06-03 Introgen Therapeutics Inc. Chromatographic methods for adenovirus purification
AU2004294403A1 (en) 2003-12-01 2005-06-16 Novo Nordisk Health Care Ag Nanofiltration of factor VII solutions to remove virus
AU2005229674B2 (en) 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
GT200600031A (es) 2005-01-28 2006-08-29 Formulacion anticuerpo anti a beta
ATE412737T1 (de) 2005-04-11 2008-11-15 Crucell Holland Bv Virusreinigung mit ultrafiltration
EP1886976A1 (en) 2006-08-09 2008-02-13 Thermphos Trading GmbH Method of scale inhibition
US8741600B2 (en) * 2007-06-19 2014-06-03 Asahi Kasei Kabushiki Kaisha Method for separation of immunoglobulin monomers
JP5755136B2 (ja) * 2009-03-27 2015-07-29 旭化成メディカル株式会社 高濃度モノクローナル抗体溶液中のウイルス除去方法
EP4786482A2 (en) 2009-08-06 2026-08-05 F. Hoffmann-La Roche AG Virus filtration methods
PL2697369T3 (pl) 2011-03-25 2018-12-31 F.Hoffmann-La Roche Ag Nowe sposoby oczyszczania białek

Also Published As

Publication number Publication date
HRP20181357T1 (hr) 2018-10-19
TR201810703T4 (tr) 2018-08-27
SG193564A1 (en) 2013-10-30
EP2697369B1 (en) 2018-06-27
EP2697369A1 (en) 2014-02-19
US20140309403A1 (en) 2014-10-16
WO2012134987A1 (en) 2012-10-04
EP2697369A4 (en) 2015-01-21
IL228438A0 (en) 2013-12-31
CA2830640A1 (en) 2012-10-04
MX2013010737A (es) 2014-03-12
RU2013147609A (ru) 2015-04-27
HK1194434A1 (zh) 2014-10-17
US10906934B2 (en) 2021-02-02
CN103582700A (zh) 2014-02-12
KR20140022845A (ko) 2014-02-25
SI2697369T1 (sl) 2018-10-30
BR112013024521A2 (pt) 2019-09-24
NZ615579A (en) 2016-09-30
ES2685079T3 (es) 2018-10-05
CN103582700B (zh) 2016-08-17
AU2012237026A1 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
IL228438A0 (en) New methods for protein purification
IL232558B (en) A method for antibody purification
SG10201802316VA (en) Protein purification
PT2768857T (pt) Métodos para purificar anticorpos
GB201405981D0 (en) Pallet-dolly
GB201012599D0 (en) Process for purifying proteins
EP2673635A4 (en) IMMUNOTHERAPY THROUGH APOE
GB201113811D0 (en) Protein recovery
PL2760558T3 (pl) Sposób oczyszczania
GB201100282D0 (en) Biological methods
SG10201606218WA (en) Purified Proteins
GB201410312D0 (en) Photobioreactor
EP2723759A4 (en) PURIFICATION OF CHIMERIC PROTEIN
GB201105407D0 (en) Purification method
GB201119167D0 (en) Novel bachteriophages
GB201115218D0 (en) Novel process
IL229383A0 (en) A process for purifying protein with a low acidity level
EP2714713A4 (en) PURIFICATION OF ANTIBODIES
EP2768941A4 (en) photobioreactor
GB201101794D0 (en) Protein production
ZA201401261B (en) Purification process
GB201111192D0 (en) Purification process
GB201113544D0 (en) Purification process
HUP1100282A2 (en) Protein factor
GB201103169D0 (en) Protein expression